Extracellular Vesicle-derived circular RNAs confers chemoresistance in Colorectal cancer KW Hon, NS Ab-Mutalib, NMA Abdullah, R Jamal, N Abu Scientific reports 9 (1), 16497, 2019 | 108 | 2019 |
Exosomes as potential biomarkers and targeted therapy in colorectal cancer: a mini-review KW Hon, N Abu, NS Ab Mutalib, R Jamal Frontiers in pharmacology 8, 287557, 2017 | 64 | 2017 |
Identification of differentially expressed circular RNAs in chemoresistant colorectal cancer N Abu, KW Hon, S Jeyaraman, A Yahaya, NMA Abdullah, M Mustangin, ... Epigenomics 11 (8), 875-884, 2019 | 48 | 2019 |
miRNAs and lncRNAs as predictive biomarkers of response to FOLFOX therapy in colorectal cancer KW Hon, N Abu, NS Ab Mutalib, R Jamal Frontiers in pharmacology 9, 391429, 2018 | 37 | 2018 |
Long noncoding RNAs as biotargets in cisplatin-based drug resistance N Abu, KW Hon, S Jeyaraman, R Jamal Future oncology 14 (29), 3085-3095, 2018 | 32 | 2018 |
The crosstalk between signaling pathways and cancer metabolism in colorectal cancer KW Hon, SA Zainal Abidin, I Othman, R Naidu Frontiers in pharmacology 12, 768861, 2021 | 22 | 2021 |
Insights into the role of microRNAs in colorectal cancer (CRC) metabolism K Wai Hon, SA Zainal Abidin, I Othman, R Naidu Cancers 12 (9), 2462, 2020 | 17 | 2020 |
Predictive biomarkers of drug resistance in colorectal cancer—Recent updates KW Hon, N Othman, EAM Hanif, SN Nasir, NS Abd Razak, R Jamal, ... Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic …, 2020 | 2 | 2020 |
Anti-Cancer Mechanisms of Diarylpentanoid MS17 (1, 5-Bis (2-hydroxyphenyl)-1, 4-pentadiene-3-one) in Human Colon Cancer Cells: A Proteomics Approach KW Hon, SA Zainal Abidin, F Abas, I Othman, R Naidu International Journal of Molecular Sciences 25 (6), 3503, 2024 | | 2024 |
Molecular Mechanisms Underlying the Anti-cancer Activities of MS17 [1, 5-bis (2-hydroxyphenyl)-1, 4-pentadiene-3-one] and Curcumin-treated Human Colon Cancer Cells KHAWAI HON Monash University, 0 | | |